0
     

Report Added
Report already added
Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, MCOT, ECG, ICP, ILRs, Multi-parameter Monitoring, Weight Monitoring), End-User (Hospital, ASCs) - Global Forecast to 2027

Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, MCOT, ECG, ICP, ILRs, Multi-parameter Monitoring, Weight Monitoring), End-User (Hospital, ASCs) - Global Forecast to 2027

The patient monitoring devices market is anticipated to grow at a CAGR of 9.1% to reach USD 65.4 billion by 2027 from USD 42.3 billion in 2022. The growth of the market is mainly attributed to greater adoption of biosensors and connected care devices and higher demand for home-based or home-use products. However, the high cost associated with novel and advanced monitoring devices is expected to limit the market growth.

“In product segment, blood glucose monitoring systems segment will undergo a significant growth by 2027.”

Based on the product, the patient monitoring devices market is segmented into multiparameter monitoring devices, temperature monitoring devices, blood glucose monitoring systems, fetal and neonatal monitoring devices, neuromonitoring devices, weight monitoring devices, cardiac monitoring devices, hemodynamic/pressure monitoring devices, respiratory monitoring devices, and other patient monitoring devices.

The substantial growth of the segment is attributed to the technological advancements and ongoing product approval of continuous glucose monitoring systems, benefits offered by continuous monitoring systems over self-monitoring systems in the market. Continuous glucose monitoring systems offer a wide range of advantages over self-monitoring blood glucose systems, such as non-invasive detection shortened detection time, and reduced cost. These advantages among several other advantages offered by the continuous glucose monitoring systems will lead to the growth of this product segment.

“By end-user hospitals segment is anticipated to account for the major share of the patient monitoring devices market,”

By end-users, the patient monitoring devices market is segmented into home care settings, hospitals, ambulatory surgery centers, and other end users. The demand growth among hospitals is attributed to the momentous availability of state-of-the-art services for patient treatment, diagnosis, as well as trained personnel, and disease management, that has ensured a stable demand for increasing number of hospitals in major countries and the hospital-based care. More diagnostic and screening procedures are carried out in hospitals, promoting to the increased market share. The influx of patients is usually higher in hospitals as compared to other healthcare settings, which is another key driver for segment growth.

“By Region, Asia Pacific Patient Monitoring Devices Market is anticipated to grow at the highest CAGR by 2027.”

The Asia Pacific market will grow at the highest CAGR during the forecast period majorly due to the rising healthcare expenditure, heavy burden of infectious diseases, and increasing geriatric population along with favourable public and private contribution to overall healthcare infrastructure. Apart from this, the increase in the number of ambulatory surgical centers and development of infrastructure in hospitals the APAC region is expected to propel the patient monitoring devices market.

A breakdown of the primary participants referred to for this report is provided below:
•By Company Type: Tier 1–45%, Tier 2–34%, and Tier 3– 21%
•By Designation: C-level–47%, Director-level–33%, and Others–20%
•By Region: North America–35%, Europe–32%, Asia Pacific–25%, Latin America–6%, and the Middle East & Africa–2%

List of Companies Profiled in the Report
oAbbott Laboratories (US),
oHILL-ROM HOLDINGS, INC. (US),
oDrägerwerk AG & Co. KGaA (Germany),
oEdwards Lifesciences Corporation (US),
oOMRON Corporation (Japan),
oMasimo Corporation (US),
oCompumedics Limited (Australia),
oShenzhen Mindray Bio-Medical Electronics Co., Ltd. (China),
oNihon Kohden Corporation (Japan),
oNatus Medical (US), Medtronic plc (Ireland),
oKoninklijke Philips N.V. (Netherlands),
oGE Healthcare (US), Getinge AB (Sweden),
oBoston Scientific Corporation (US),
oDexcom, Inc. (US),
oNonin (US),
oBIOTRONIK (Germany),
oSCHILLER (Switzerland),
oBioTelemetry, Inc. (US)

Research Coverage
This report studies the patient monitoring devices market based on product, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the patient monitoring devices market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the patient monitoring devices market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the patient monitoring devices market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Table of Contents

1INTRODUCTION45
1.1STUDY OBJECTIVES45
1.2MARKET DEFINITION45
TABLE 1INCLUSIONS AND EXCLUSIONS45
1.3STUDY SCOPE46
FIGURE 1PATIENT MONITORING DEVICES MARKET46
FIGURE 2PATIENT MONITORING DEVICES MARKET, BY GEOGRAPHY46
1.4YEARS CONSIDERED47
1.5CURRENCY CONSIDERED47
1.6STAKEHOLDERS47
1.7SUMMARY OF CHANGES48
2RESEARCH METHODOLOGY49
2.1RESEARCH DATA49
2.2RESEARCH DESIGN49
FIGURE 3PATIENT MONITORING DEVICES MARKET: RESEARCH DESIGN49
2.2.1SECONDARY DATA50
2.2.2PRIMARY DATA51
FIGURE 4PRIMARY SOURCES51
2.2.2.1Key data from primary sources52
2.2.2.2Insights from primary experts52
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS53
FIGURE 6BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION53
2.3MARKET SIZE ESTIMATION54
FIGURE 7SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS54
FIGURE 8TOP-DOWN APPROACH55
2.4DATA TRIANGULATION57
FIGURE 9DATA TRIANGULATION METHODOLOGY57
2.5MARKET SHARE ESTIMATION58
2.6RESEARCH ASSUMPTIONS58
2.7LIMITATIONS58
2.8RISK ASSESSMENT59
TABLE 2LIMITATIONS AND ASSOCIATED RISKS59
3EXECUTIVE SUMMARY60
FIGURE 10PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)60
FIGURE 11PATIENT MONITORING DEVICES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)61
FIGURE 12ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD62
4PREMIUM INSIGHTS63
4.1PATIENT MONITORING DEVICES MARKET OVERVIEW63
FIGURE 13TECHNOLOGICAL ADVANCEMENTS AND RISING DISEASE INCIDENCE TO DRIVE DEMAND FOR PATIENT MONITORING DEVICES63
4.2ASIA PACIFIC: PATIENT MONITORING DEVICES MARKET SHARE, BY COUNTRY & PRODUCT64
FIGURE 14JAPAN HOLDS LARGEST HIGHEST SHARE OF APAC MARKET64
4.3PATIENT MONITORING DEVICES MARKET SHARE, BY END USER65
FIGURE 15HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING 2022–202765
4.4GEOGRAPHICAL SNAPSHOT OF THE PATIENT MONITORING DEVICES MARKET65
FIGURE 16MARKET IN CHINA TO GROW AT HIGHEST RATE DURING 2022–202765
5MARKET OVERVIEW66
5.1INTRODUCTION66
5.2MARKET DYNAMICS66
FIGURE 17PATIENT MONITORING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES66
5.2.1DRIVERS67
5.2.1.1Increasing technological advancements and innovations67
5.2.1.1.1Increased user-centric designs for wearable devices67
5.2.1.1.2Growing use of non-invasive hemodynamic monitoring68
5.2.1.1.3Rising use of digital data sensors68
5.2.1.1.4Growing use of mobile-grade EEG devices69
5.2.1.2Rising prevalence of chronic diseases69
5.2.1.3Availability of wireless monitoring devices71
TABLE 3RECENT PRODUCT INNOVATIONS IN PATIENT MONITORING DEVICES MARKET72
5.2.1.4Growing preference for wearable patient monitoring devices, biosensors, and smart implants72
5.2.1.5Growing investments, funds, and grants in healthcare systems73
5.2.2RESTRAINTS74
5.2.2.1Risks associated with invasive monitoring devices74
5.2.2.2High cost of patient monitoring products and inadequate reimbursement75
5.2.3OPPORTUNITIES75
5.2.3.1Increasing demand for non-invasive and minimally invasive devices75
5.2.3.2Growing demand for patient monitoring devices in non-hospital settings76
5.2.4CHALLENGES76
5.2.4.1Lack of skilled healthcare professionals76
5.2.4.2Increased pricing pressure on market players77
5.3VALUE CHAIN ANALYSIS78
FIGURE 18VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE78
5.4ECOSYSTEM ANALYSIS79
5.5REGULATORY ANALYSIS79
5.5.1NORTH AMERICA79
5.5.1.1US79
TABLE 4US FDA: MEDICAL DEVICE CLASSIFICATION80
TABLE 5US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS80
5.5.1.2Canada80
TABLE 6CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS81
FIGURE 19CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES81
5.5.2EUROPE82
FIGURE 20EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)83
5.5.3ASIA PACIFIC84
5.5.3.1Japan84
TABLE 7JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA84
5.5.3.2China85
TABLE 8CHINA: CLASSIFICATION OF MEDICAL DEVICES85
5.5.3.3India86
5.6TRADE ANALYSIS87
TABLE 9IMPORT DATA FOR PATIENT MONITORS (HS CODE 901890), BY COUNTRY, 2017- 2021 (USD MILLION)87
TABLE 10EXPORT DATA FOR PATIENT MONITORS (HS CODE 901890), BY COUNTRY, 2017- 2021 (USD MILLION)87
5.7KEY CONFERENCES AND EVENTS IN 2022–202388
TABLE 11DETAILED LIST OF MAJOR CONFERENCES AND EVENTS88
6PATIENT MONITORING DEVICES MARKET, BY PRODUCT89
6.1INTRODUCTION90
TABLE 12PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)90
6.2BLOOD GLUCOSE MONITORING SYSTEMS91
TABLE 13BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)91
TABLE 14BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)91
TABLE 15BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2020–2027 (USD MILLION)92
6.2.1SELF-MONITORING BLOOD GLUCOSE SYSTEMS92
6.2.1.1Rising adoption of integrated glucose monitoring systems to drive growth92
TABLE 16SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)93
6.2.2CONTINUOUS GLUCOSE MONITORING SYSTEMS94
6.2.2.1Product launches and evolving reimbursement scenarios for continuous monitoring systems to drive market growth94
TABLE 17CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)95
6.3CARDIAC MONITORING DEVICES95
TABLE 18CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)95
TABLE 19CARDIAC MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)96
TABLE 20CARDIAC MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)96
6.3.1ECG DEVICES97
6.3.1.1Low cost and wide applications of ECG devices to drive market growth97
TABLE 21ECG DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)98
6.3.2IMPLANTABLE LOOP RECORDERS98
6.3.2.1High cost and limited applications limit growth98
TABLE 22IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2020–2027 (USD MILLION)99
6.3.3EVENT MONITORS99
6.3.3.1Emergence of portable and wireless event monitors to drive market growth99
TABLE 23EVENT MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)100
6.3.4MCT MONITORS100
6.3.4.1Availability of alternate technologies likely to hinder market growth100
TABLE 24MCT MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)101
6.3.5SMART/WEARABLE ECG MONITORS101
6.3.5.1Need to minimize treatment costs for CVD patients to increase adoption of smart/wearable ECG monitors101
TABLE 25SMART/WEARABLE ECG MONITORS OFFERED BY MARKET PLAYERS102
TABLE 26SMART/WEARABLE ECG MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)103
6.4MULTI-PARAMETER MONITORING DEVICES103
TABLE 27MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)103
TABLE 28MULTI-PARAMETER MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)104
TABLE 29MULTI-PARAMETER MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)104
6.4.1LOW-ACUITY MONITORING DEVICES104
6.4.1.1Increasing adoption of low-acuity monitoring devices to improve care in general wards drives market growth104
TABLE 30LOW-ACUITY MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)105
6.4.2MID-ACUITY MONITORING DEVICES105
6.4.2.1Rising geriatric population is likely to increase market growth105
TABLE 31MID-ACUITY MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)105
6.4.3HIGH-ACUITY MONITORING DEVICES106
6.4.3.1Increasing partnerships between manufacturers and hospitals drive device sales106
TABLE 32HIGH-ACUITY MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)106
6.5RESPIRATORY MONITORING DEVICES106
TABLE 33RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)107
TABLE 34RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)107
TABLE 35RESPIRATORY MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)108
6.5.1PULSE OXIMETERS108
6.5.1.1Rising adoption of pulse oximeters in home care settings to drive market growth108
TABLE 36PULSE OXIMETERS MARKET, BY REGION, 2020–2027 (USD MILLION)109
6.5.2SPIROMETERS109
6.5.2.1Technological advancements to increase the adoption of spirometers109
TABLE 37SPIROMETERS MARKET, BY REGION, 2020–2027 (USD MILLION)110
6.5.3CAPNOGRAPHS110
6.5.3.1Product development and growing commercial acceptance to drive market growth110
TABLE 38CAPNOGRAPHS MARKET, BY REGION, 2020–2027 (USD MILLION)111
6.5.4PEAK FLOW METERS111
6.5.4.1Low preference for peak flow meters due to high variability in measurements from different devices hinders market growth111
TABLE 39PEAK FLOW METERS MARKET, BY REGION, 2020–2027 (USD MILLION)112
6.6TEMPERATURE MONITORING DEVICES112
TABLE 40TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)112
TABLE 41TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)113
TABLE 42TEMPERATURE MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)113
6.6.1HANDHELD TEMPERATURE MONITORING DEVICES113
6.6.1.1Advantages associated with handheld temperature monitoring devices to drive market growth113
TABLE 43HANDHELD TEMPERATURE MONITORING DEVICES OFFERED BY MARKET PLAYERS114
TABLE 44HANDHELD TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)115
6.6.2TABLE-TOP TEMPERATURE MONITORING DEVICES115
6.6.2.1Increasing risks associated with hypothermia during surgeries to drive demand for table-top devices115
TABLE 45TABLE-TOP TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)116
6.6.3WEARABLE CONTINUOUS MONITORING DEVICES116
6.6.3.1Versatile functionalities offered by wearable continuous monitoring devices to drive demand116
TABLE 46WEARABLE CONTINUOUS MONITORING DEVICES OFFERED BY MARKET PLAYERS117
TABLE 47WEARABLE CONTINUOUS MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)117
6.6.4INVASIVE TEMPERATURE MONITORING DEVICES118
6.6.4.1Risk of bloodstream infections associated with catheter usage hinders market for invasive devices118
TABLE 48INVASIVE TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)118
6.6.5SMART TEMPERATURE MONITORING PATCHES119
6.6.5.1Long-term monitoring capabilities of smart patches to drive market growth119
TABLE 49SMART TEMPERATURE MONITORING PATCHES OFFERED BY MARKET PLAYERS119
TABLE 50SMART TEMPERATURE MONITORING PATCHES MARKET, BY REGION, 2020–2027 (USD MILLION)120
6.7HEMODYNAMIC/PRESSURE MONITORING DEVICES120
TABLE 51HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)120
TABLE 52HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)121
TABLE 53HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)121
6.7.1HEMODYNAMIC MONITORS122
6.7.1.1Influx of VC funding to drive market growth122
TABLE 54HEMODYNAMIC MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)122
6.7.2BLOOD PRESSURE MONITORS123
6.7.2.1Development of wearable blood pressure monitors to drive market growth123
TABLE 55WEARABLE BLOOD PRESSURE MONITORS OFFERED BY MARKET PLAYERS123
TABLE 56BLOOD PRESSURE MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)124
6.7.3DISPOSABLES124
6.7.3.1Growing number of surgical procedures to drive growth in disposables market124
TABLE 57HEMODYNAMIC/PRESSURE MONITORING DISPOSABLES MARKET, BY REGION, 2020–2027 (USD MILLION)124
6.8FETAL & NEONATAL MONITORING DEVICES125
TABLE 58FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)125
TABLE 59FETAL & NEONATAL MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)125
TABLE 60FETAL & NEONATAL MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)126
6.8.1FETAL MONITORING DEVICES126
6.8.1.1Rising prevalence of obstetric complications, growing pre-term birth rate drive market growth126
TABLE 61WEARABLE FETAL MONITORING & OBSTETRIC DEVICES OFFERED BY MARKET PLAYERS128
TABLE 62FETAL MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)128
6.8.2NEONATAL MONITORING DEVICES128
6.8.2.1Rising number of neonatal care facilities worldwide to drive market128
TABLE 63NEONATAL MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)129
6.9NEUROMONITORING DEVICES129
TABLE 64NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)130
TABLE 65NEUROMONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)130
TABLE 66NEUROMONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)131
6.9.1EEG MACHINES131
6.9.1.1Growing applications and technological advancements form key market growth drivers131
TABLE 67EEG MACHINES MARKET, BY REGION, 2020–2027 (USD MILLION)132
6.9.2EMG MACHINES132
6.9.2.1Availability of reimbursements for EMG-assisted surgeries boosts product demand132
TABLE 68EMG MACHINES MARKET, BY REGION, 2020–2027 (USD MILLION)133
6.9.3CEREBRAL OXIMETERS133
6.9.3.1Growing cases of hypoxia during surgical procedures to drive market growth133
TABLE 69CEREBRAL OXIMETERS MARKET, BY REGION, 2020–2027 (USD MILLION)134
6.9.4ICP MONITORS134
6.9.4.1Growing incidence of post-surgical cerebrovascular complications and TBIs support adoption of ICP monitors134
TABLE 70ICP MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)135
6.9.5MEG MACHINES135
6.9.5.1High implementation and maintenance costs of MEG devices likely to hinder market growth135
TABLE 71MEG MACHINES MARKET, BY REGION, 2020–2027 (USD MILLION)136
6.9.6TCD MACHINES136
6.9.6.1Rising prevalence of strokes and cerebrovascular disorders will contribute to market growth136
TABLE 72TCD MACHINES MARKET, BY REGION, 2020–2027 (USD MILLION)136
6.10WEIGHT MONITORING DEVICES137
TABLE 73WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)137
TABLE 74WEIGHT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)137
TABLE 75WEIGHT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)138
6.10.1DIGITAL WEIGHT MONITORING DEVICES138
6.10.1.1Consumer preference for digital scales—a key market driver138
TABLE 76DIGITAL WEIGHT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)138
6.10.2ANALOG WEIGHT MONITORING DEVICES139
6.10.2.1Rising prevalence of obesity and low cost of analog scales support market growth139
TABLE 77ANALOG WEIGHT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)139
6.11OTHER PATIENT MONITORING DEVICES140
TABLE 78POLYSOMNOGRAPHY DEVICES OFFERED BY VARIOUS PLAYERS140
TABLE 79WEARABLE SLEEP MONITORING DEVICES OFFERED BY MARKET PLAYERS141
TABLE 80OTHER PATIENT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)141
TABLE 81OTHER PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)142
7PATIENT MONITORING DEVICES MARKET, BY END USER143
7.1INTRODUCTION144
TABLE 82PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)144
7.2HOSPITALS144
7.2.1HOSPITALS TO DOMINATE END-USER MARKET144
TABLE 83PATIENT MONITORING DEVICES MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)145
7.3AMBULATORY SURGERY CENTERS145
7.3.1COST-EFFECTIVENESS AND CONVENIENCE DRIVE DEMAND FOR AMBULATORY CARE145
TABLE 84PATIENT MONITORING DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2020–2027 (USD MILLION)146
7.4HOME CARE SETTINGS146
7.4.1REDUCED COST AND CONTINUOUS MONITORING OF VITAL INFORMATION IN HOME SETTINGS TO BOOST GROWTH146
TABLE 85PATIENT MONITORING DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)147
7.5OTHER END USERS147
TABLE 86PATIENT MONITORING DEVICES MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)148
8PATIENT MONITORING DEVICES MARKET, BY REGION149
8.1INTRODUCTION150
TABLE 87PATIENT MONITORING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)150
8.2NORTH AMERICA151
FIGURE 21NORTH AMERICA: PATIENT MONITORING DEVICES MARKET SNAPSHOT151
TABLE 88NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)152
TABLE 89NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)152
TABLE 90NORTH AMERICA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)153
TABLE 91NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)153
TABLE 92NORTH AMERICA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)154
TABLE 93NORTH AMERICA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)154
TABLE 94NORTH AMERICA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)155
TABLE 95NORTH AMERICA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)155
TABLE 96NORTH AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)156
TABLE 97NORTH AMERICA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)156
TABLE 98NORTH AMERICA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)157
TABLE 99NORTH AMERICA: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)157
8.2.1US157
8.2.1.1Growing number of FDA approvals for patient monitoring devices to support market growth157
TABLE 100VC FUNDING IN THE PATIENT MONITORING DEVICES MARKET IN THE US158
TABLE 101US: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)159
TABLE 102US: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)159
TABLE 103US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)160
TABLE 104US: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)160
TABLE 105US: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)160
TABLE 106US: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)161
TABLE 107US: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)161
TABLE 108US: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)162
TABLE 109US: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)162
TABLE 110US: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)162
8.2.2CANADA163
8.2.2.1Growing public-private funding for research to drive market growth163
TABLE 111RESEARCH GRANTS IN THE PATIENT MONITORING DEVICES MARKET IN CANADA163
TABLE 112RECENT DEVELOPMENTS IN THE CANADIAN PATIENT MONITORING DEVICES MARKET164
TABLE 113CANADA: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)165
TABLE 114CANADA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)166
TABLE 115CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)166
TABLE 116CANADA: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)167
TABLE 117CANADA: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)167
TABLE 118CANADA: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)168
TABLE 119CANADA: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)168
TABLE 120CANADA: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)169
TABLE 121CANADA: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)169
TABLE 122CANADA: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)169
8.3EUROPE170
TABLE 123PRODUCT APPROVALS IN THE EUROPEAN PATIENT MONITORING DEVICES MARKET170
TABLE 124EUROPE: PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)170
TABLE 125EUROPE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)171
TABLE 126EUROPE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)171
TABLE 127EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)172
TABLE 128EUROPE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)172
TABLE 129EUROPE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)173
TABLE 130EUROPE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)173
TABLE 131EUROPE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)174
TABLE 132EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)174
TABLE 133EUROPE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)175
TABLE 134EUROPE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)175
TABLE 135EUROPE: PATIENT MONITORING DEVICES MARKET, BY END USER, 2020–2027 (USD MILLION)176
8.3.1GERMANY176
8.3.1.1Rising healthcare expenditure and manufacturer expansion to boost market growth176
TABLE 136GERMANY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)177
TABLE 137GERMANY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)178
TABLE 138GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)178
TABLE 139GERMANY: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)179
TABLE 140GERMANY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)179
TABLE 141GERMANY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)180
TABLE 142GERMANY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)180
TABLE 143GERMANY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)181
TABLE 144GERMANY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)181
TABLE 145GERMANY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)181
8.3.2UK182
8.3.2.1Increasing public & private investments contribute to market growth182
TABLE 146UK: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)183
TABLE 147UK: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)183
TABLE 148UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)184
TABLE 149UK: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)184
TABLE 150UK: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)185
TABLE 151UK: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)185
TABLE 152UK: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)186
TABLE 153UK: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)186
TABLE 154UK: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)187
TABLE 155UK: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)187
8.3.3FRANCE187
8.3.3.1Statutory health insurance system to support market growth187
TABLE 156FRANCE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)188
TABLE 157FRANCE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)189
TABLE 158FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)189
TABLE 159FRANCE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)190
TABLE 160FRANCE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)190
TABLE 161FRANCE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)191
TABLE 162FRANCE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)191
TABLE 163FRANCE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)192
TABLE 164FRANCE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)192
TABLE 165FRANCE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)192
8.3.4ITALY193
8.3.4.1Rising incidence of lifestyle diseases to drive adoption of patient monitoring devices193
TABLE 166ITALY: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)194
TABLE 167ITALY: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)195
TABLE 168ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)195
TABLE 169ITALY: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)196
TABLE 170ITALY: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)196
TABLE 171ITALY: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)197
TABLE 172ITALY: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)197
TABLE 173ITALY: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)198
TABLE 174ITALY: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)198
TABLE 175ITALY: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)199
8.3.5SPAIN199
8.3.5.1Growing number of surgical procedures to drive market growth in Spain199
TABLE 176SPAIN: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)200
TABLE 177SPAIN: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)201
TABLE 178SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)201
TABLE 179SPAIN: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)202
TABLE 180SPAIN: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)202
TABLE 181SPAIN: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)203
TABLE 182SPAIN: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)203
TABLE 183SPAIN: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)204
TABLE 184SPAIN: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)204
TABLE 185SPAIN: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)205
8.3.6REST OF EUROPE205
TABLE 186KEY MERGERS & ACQUISITIONS AND PARTNERSHIPS IN THE PATIENT MONITORING DEVICES MARKET IN THE ROE205
TABLE 187ROE: PATIENT MONITORING DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)206
TABLE 188ROE: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)207
TABLE 189ROE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)207
TABLE 190ROE: MULTI-PARAMETER MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)208
TABLE 191ROE: RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)208
TABLE 192ROE: TEMPERATURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)209
TABLE 193ROE: HEMODYNAMIC/PRESSURE MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)209
TABLE 194ROE: FETAL & NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)210
TABLE 195ROE: NEUROMONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)210
TABLE 196ROE: WEIGHT MONITORING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)211

Report Title: Patient Monitoring Devices Market by Product (EEG, MEG, TCD, Pulse Oximeter, Spirometer, Fetal Monitor, Temperature Monitor, MCOT, ECG, ICP, ILRs, Multi-parameter Monitoring, Weight Monitoring), End-User (Hospital, ASCs) - Global Forecast to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Animal Type (Snake, Spider, Bee, Others), By Source (Whole Venom, Synthetic, Recombinant, Others), By Therapeutic Area (Hypertension, Cardiovascular Diseases, Neurological Disorders, Pain Management & Arthritis, Others), By Company and By Region

Venom Based Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Animal Type (Snake, Spider, Bee, Others), By Source (Whole Venom, Synthetic, Recombinant, Others), By Therapeutic Area (Hypertension, Cardiovascular Diseases, Neurological Disorders, Pain Management & Arthritis, Others), By Company and By Region

Phage Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Bacteria Type (Salmonella, Bacteriophage, Streptococcus, E.Coli, Others), By Product (Oral Consumption, External Consumption, Surgical Treatment), By Application (Human Medicines, Veterinary Sciences, Food & Beverage, Others), and By Region

Phage Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Bacteria Type (Salmonella, Bacteriophage, Streptococcus, E.Coli, Others), By Product (Oral Consumption, External Consumption, Surgical Treatment), By Application (Human Medicines, Veterinary Sciences, Food & Beverage, Others), and By Region

Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies), By Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region

Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies), By Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region

Medication Reminder Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Type (Mobile Phone Reminders, In-Home Electronic Devices, Portable Reminder Devices), By End User (Homecare, Hospitals & Clinics, Others), By Company and By Region

Medication Reminder Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type (Mobile Phone Reminders, In-Home Electronic Devices, Portable Reminder Devices), By End User (Homecare, Hospitals & Clinics, Others), By Company and By Region

Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Valence (Bivalent, Quadrivalent, Nonvalent, Others), By Disease Indication (Cervical Cancer, Anal Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, Others), By Distribution Channel (Hospitals & Clinics, Governmental & Non-Governmental Organizations, Public & Private Alliances, Others), By Company and By Region

Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Valence (Bivalent, Quadrivalent, Nonvalent, Others), By Disease Indication (Cervical Cancer, Anal Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, Others), By Distribution Channel (Hospitals & Clinics, Governmental & Non-Governmental Organizations, Public & Private Alliances, Others), By Company and By Region

Hand, Foot, and Mouth Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027
Segmented By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals), By Route of Administration (Topical, Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Company, and By Region

Hand, Foot, and Mouth Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals), By Route of Administration (Topical, Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Company, and By Region